Spots Global Cancer Trial Database for amg 386 placebo iv
Every month we try and update this database with for amg 386 placebo iv cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib | NCT00467025 | Advanced Renal ... | AMG 386 Sorafenib AMG 386 placebo... | 18 Years - | Amgen | |
| AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib | NCT00467025 | Advanced Renal ... | AMG 386 Sorafenib AMG 386 placebo... | 18 Years - | Amgen |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
